Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma

Table 4

Multivariate analysis of clinical factors for PFS and OS according to NLR.

Characteristics	OS			PFS
	HR	95%CI	P value	HR	95%CI	P value
B symptoms	1.302	0.669-2.535	0.437	1.494	0.772-2.892	0.233
ECOG PS (⩾2)	0.690	0.213-2.237	0.537	0.661	0.204-2.146	0.491
LDH (>ULN)	1.701	0.720-4.015	0.046	1.879	0.807-4.377	0.044
Stage (III and IV)	0.700	0.297-1.649	0.415	0.697	0.295-1.648	0.411
IPI (>2)	1.326	0.743-2.366	0.039	1.223	0.685-2.181	0.046
Extranodal sites of disease (>1)	1.293	0.483-3.461	0.609	1.314	0.489-3.532	0.588
NLR⩾150	1.564	0.853-2.867	0.148	1.527	0.830-2.809	0.173